AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H2644-H2649, 2007. First published August 31, 2007; doi:10.1152/ajpheart.00748.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/H2644    most recent
00748.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welch, W. J.
Right arrow Articles by Wilcox, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welch, W. J.
Right arrow Articles by Wilcox, C. S.

CALL FOR PAPERS
Cardiovascular-Renal Mechanisms in Health and Disease

Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension

William J. Welch, Kinjal Patel, Paul Modlinger, Margarida Mendonca, Noritaka Kawada, Kathryn Dennehy, Shakil Aslam, and Christopher S. Wilcox

Division of Nephrology and Hypertension, Georgetown University, Washington DC

Submitted 28 June 2007 ; accepted in final form 30 August 2007

Angiotensin (ANG) II activating type 1 receptors (AT1Rs) enhances superoxide anion (O2bullet) and arachidonate (AA) formation. AA is metabolized by cyclooxygenases (COXs) to PGH2, which is metabolized by thromboxane (Tx)A2 synthase to TxA2 or oxidized to 8-isoprostane PGF2{alpha} (8-Iso) by O2bullet. PGH2, TxA2, and 8-Iso activate thromboxane-prostanoid receptors (TPRs). We investigated whether blood pressure in a rat model of early (3 wk) two-kidney, one-clip (2K,1C) Goldblatt hypertension is maintained by AT1Rs or AT2Rs, driving COX-1 or -2-dependent products that activate TPRs. Compared with sham-operated rats, 2K,1C Goldblatt rats had increased mean arterial pressure (MAP; 120 ± 4 vs. 155 ± 3 mmHg; P < 0.001), plasma renin activity (PRA; 22 ± 7 vs. 48 ± 5 ng·ml–1·h–1; P < 0.01), plasma malondialdehyde (1.07 ± 0.05 vs. 1.58 ± 0.16 nmol/l; P < 0.01), and TxB2 excretion (26 ± 4 vs. 51 ± 7 ng/24 h; P < 0.01). Acute graded intravenous doses of benazeprilat (angiotensin-converting enzyme inhibitor) reduced MAP at 20 min (–36 ± 5 mmHg; P < 0.001) and excretion of TxA2 metabolites. Indomethacin (nonselective COX antagonist) or SC-560 (COX-1 antagonist) reduced MAP at 20 min (–25 ± 5 and –28 ± 7 mmHg; P < 0.001), whereas valdecoxib (COX-2 antagonist) was ineffective (–9 ± 5 mmHg; not significant). Losartan (AT1R antagonist) or SQ-29548 (TPR antagonist) reduced MAP at 150 min (–24 ± 6 and –22 ± 3 mmHg; P < 0.001), whereas PD-123319 (AT2R antagonist) was ineffective. Acute blockade of TPRs, COX-1, or COX-2 did not change PRA, but TxB2 generation by the clipped kidney was reduced by blockade of COX-1 and increased by blockade of COX-2. 2K,1C hypertension in rats activates renin, O2bullet, and vasoconstrictor PGs. Hypertension is maintained by AT1Rs and by COX-1, but not COX-2, products that activate TPRs.

renovascular hypertension; angiotensin receptor blocker; thromboxane A2; isoprostane; angiotensin-converting enzyme inhibition



Address for reprint requests and other correspondence: C. S. Wilcox, Georgetown Univ., 3800 Reservoir Rd., NW, PHC F6003, Washington DC 20007 (e-mail: wilcoxch{at}georgetown.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Z. Ying, F. R.C. Giachini, R. C. Tostes, and R. C. Webb
Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation
Cardiovasc Res, July 1, 2009; 83(1): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, R. Colucci, D. Versari, N. Ghisu, M. Fornai, L. Antonioli, E. Duranti, E. Daghini, C. Giannarelli, C. Blandizzi, et al.
Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats: Role of Cyclooxygenase 2-Derived Contracting Prostanoids
Hypertension, June 1, 2009; 53(6): 1008 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.